{"id":22890,"date":"2024-02-15T09:15:51","date_gmt":"2024-02-15T08:15:51","guid":{"rendered":"https:\/\/mabdesign.fr\/?p=22890"},"modified":"2025-03-27T11:10:18","modified_gmt":"2025-03-27T10:10:18","slug":"marjet-neurological-disorders","status":"publish","type":"post","link":"https:\/\/mabdesign.fr\/en\/marjet-neurological-disorders\/","title":{"rendered":"Neurological disorders"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

MabDesign’s market analyses give you a monthly overview of market dynamics and projects<\/span> in development for a given indication or technology, to help you better understand the constantly evolving market of biologics and biomanufacturing. This month, we take a look at the neurological disorders market and the biotherapies in development targeting this therapeutic area. <\/span><\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Neurological disorders affect nearly a billion people<\/strong> worldwide, and with the ageing of the population, this figure is set to continue rising in the future. These conditions have a significant impact on patients’ quality of life, and represent major challenges in terms of treatment and management. <\/p>\n

In the pipeline of projects under development, two types of biotherapies are most represented:gene therapies<\/strong><\/a>(25%) and monoclonal antibodies<\/strong><\/a> (19%). Gene therapy approaches offer promising possibilities for specifically targeting the molecular mechanisms underlying<\/strong> neurological disorders, paving the way for more effective, targeted treatments.<\/p>\n

Among the most targeted neurological disorders are Alzheimer’s disease, Parkinson’s disease and, amyotrophic lateral sclerosis<\/strong><\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Biologics in development targeting an indication for neurological disorders, by type of molecule <\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
<\/h5><\/div>\n\t\t
\n\t\t\t<\/canvas>\n\t\t<\/div>\n\n\t\t<\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

neurological disorders market
Top 3 indications<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"indications\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

***Lou Gehrig’s Disease<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

There is considerable interest in this therapeutic area, and the market is dynamic<\/strong>, as illustrated by the number of deals over the last ten years (2013-2023): 374 licensing agreements<\/strong> and 200 acquisitions<\/strong>. 2024 seems to follow this dynamic, with already two major deals in January<\/strong>. <\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

neurological disorders market: recent trends and deals <\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

deals 2013-2023<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Recent deals (2024)<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
licensing agreements<\/div>\t\t\t
\n\t\t\t\t<\/span>\n\t\t\t\t0<\/span>\n\t\t\t\t<\/span>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
acquisitions<\/div>\t\t\t
\n\t\t\t\t<\/span>\n\t\t\t\t0<\/span>\n\t\t\t\t<\/span>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"Novartis\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

January 2024<\/strong><\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Novartis Pharma AG has announced a strategic collaboration and capsid license agreement with Voyager Therapeutics Inc. with an initial payment of $100 million. <\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"deal\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

January 2024<\/strong><\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Vect-Horus signs exclusive licensing agreement with Ionis Pharmaceuticals<\/span><\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Download our infographic<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Neurological disorders market<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"troubles\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
<\/path><\/svg><\/span>Download in .pdf format<\/span><\/span><\/small><\/span><\/a>\n<\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Want to find out more? <\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

MabDesign has acquired and cultivates its expertise in all market segments associated with biopharmaceuticals and biomanufacturing. Our team<\/a> of consultants is at your disposal to support you in all your biotherapy-related projects. Feel free to explore our range of services<\/a>, including our marketing and strategic analyses<\/a>, if you’d like to find out more!<\/i><\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tContact us<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Sources: MabDesign, GlobalData<\/p>\n

Date – February 2024<\/span><\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

This month’s market analysis by MabDesign gives you an overview of market dynamics and projects in development targeting neurological disorders. <\/p>\n","protected":false},"author":4,"featured_media":22778,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[88,119],"tags":[133,135,163,257,131,132,259,134,120,255,256],"class_list":["post-22890","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-bio-hub-en","category-market-analysis-en","tag-alzheimer-en","tag-amyotrophic-lateral-sclerosis","tag-biomedicaments-en","tag-cell-and-gene-therapy","tag-neurological-disorders-en","tag-neurological-disorders-en-2","tag-other-biologics","tag-parkinson-en","tag-pipeline-en","tag-therapeutic-antibodies-and-proteins","tag-vaccines-en"],"yoast_head":"\nMarket Neurological disorders - MabDesign<\/title>\n<meta name=\"description\" content=\"MabDesign's market analysis gives you an overview of market dynamics and projects in development targeting neurological disorders.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mabdesign.fr\/en\/marjet-neurological-disorders\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Market Neurological disorders - MabDesign\" \/>\n<meta property=\"og:description\" content=\"MabDesign's market analysis gives you an overview of market dynamics and projects in development targeting neurological disorders.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mabdesign.fr\/en\/marjet-neurological-disorders\/\" \/>\n<meta property=\"og:site_name\" content=\"MabDesign\" \/>\n<meta property=\"article:published_time\" content=\"2024-02-15T08:15:51+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-27T10:10:18+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/03\/Neurology-Market-flyer.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1500\" \/>\n\t<meta property=\"og:image:height\" content=\"2000\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Anabelle Perrier\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:site\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Anabelle Perrier\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/mabdesign.fr\/en\/marjet-neurological-disorders\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/marjet-neurological-disorders\/\"},\"author\":{\"name\":\"Anabelle Perrier\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/4643f9d895805d8377e2471c8e4d6918\"},\"headline\":\"Neurological disorders\",\"datePublished\":\"2024-02-15T08:15:51+00:00\",\"dateModified\":\"2025-03-27T10:10:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/marjet-neurological-disorders\/\"},\"wordCount\":349,\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/marjet-neurological-disorders\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/03\/Neurology-Market-flyer.png\",\"keywords\":[\"Alzheimer\",\"amyotrophic lateral sclerosis\",\"biom\u00e9dicaments\",\"Cell and Gene therapy\",\"neurological disorders\",\"neurological disorders\",\"Other Biologics\",\"Parkinson\",\"pipeline\",\"Therapeutic antibodies and proteins\",\"Vaccines\"],\"articleSection\":[\"Bio-hub\",\"Market analysis\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/mabdesign.fr\/en\/marjet-neurological-disorders\/\",\"url\":\"https:\/\/mabdesign.fr\/en\/marjet-neurological-disorders\/\",\"name\":\"Market Neurological disorders - MabDesign\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/marjet-neurological-disorders\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/marjet-neurological-disorders\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/03\/Neurology-Market-flyer.png\",\"datePublished\":\"2024-02-15T08:15:51+00:00\",\"dateModified\":\"2025-03-27T10:10:18+00:00\",\"description\":\"MabDesign's market analysis gives you an overview of market dynamics and projects in development targeting neurological disorders.\",\"breadcrumb\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/marjet-neurological-disorders\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/mabdesign.fr\/en\/marjet-neurological-disorders\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/marjet-neurological-disorders\/#primaryimage\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/03\/Neurology-Market-flyer.png\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/03\/Neurology-Market-flyer.png\",\"width\":1500,\"height\":2000,\"caption\":\"troubles neurologiques, pipeline, march\u00e9, neurological disorders\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/mabdesign.fr\/en\/marjet-neurological-disorders\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/mabdesign.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Neurological disorders\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"name\":\"Mabdesign\",\"description\":\"The Biotherapy Expert\",\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/mabdesign.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\",\"name\":\"Mabdesign\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"width\":786,\"height\":233,\"caption\":\"Mabdesign\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/MabDesign_fr\",\"https:\/\/www.linkedin.com\/company\/mabdesign\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/4643f9d895805d8377e2471c8e4d6918\",\"name\":\"Anabelle Perrier\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f3a0b000cbed04b58d93c3453cafdf5ef34c998ff91ba6a81b173a075a0bfae2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f3a0b000cbed04b58d93c3453cafdf5ef34c998ff91ba6a81b173a075a0bfae2?s=96&d=mm&r=g\",\"caption\":\"Anabelle Perrier\"},\"url\":\"https:\/\/mabdesign.fr\/en\/author\/anabelle-perriermabdesign-fr\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Market Neurological disorders - MabDesign","description":"MabDesign's market analysis gives you an overview of market dynamics and projects in development targeting neurological disorders.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mabdesign.fr\/en\/marjet-neurological-disorders\/","og_locale":"en_US","og_type":"article","og_title":"Market Neurological disorders - MabDesign","og_description":"MabDesign's market analysis gives you an overview of market dynamics and projects in development targeting neurological disorders.","og_url":"https:\/\/mabdesign.fr\/en\/marjet-neurological-disorders\/","og_site_name":"MabDesign","article_published_time":"2024-02-15T08:15:51+00:00","article_modified_time":"2025-03-27T10:10:18+00:00","og_image":[{"width":1500,"height":2000,"url":"http:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/03\/Neurology-Market-flyer.png","type":"image\/png"}],"author":"Anabelle Perrier","twitter_card":"summary_large_image","twitter_creator":"@MabDesign_fr","twitter_site":"@MabDesign_fr","twitter_misc":{"Written by":"Anabelle Perrier","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mabdesign.fr\/en\/marjet-neurological-disorders\/#article","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/marjet-neurological-disorders\/"},"author":{"name":"Anabelle Perrier","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/4643f9d895805d8377e2471c8e4d6918"},"headline":"Neurological disorders","datePublished":"2024-02-15T08:15:51+00:00","dateModified":"2025-03-27T10:10:18+00:00","mainEntityOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/marjet-neurological-disorders\/"},"wordCount":349,"publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/marjet-neurological-disorders\/#primaryimage"},"thumbnailUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/03\/Neurology-Market-flyer.png","keywords":["Alzheimer","amyotrophic lateral sclerosis","biom\u00e9dicaments","Cell and Gene therapy","neurological disorders","neurological disorders","Other Biologics","Parkinson","pipeline","Therapeutic antibodies and proteins","Vaccines"],"articleSection":["Bio-hub","Market analysis"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/mabdesign.fr\/en\/marjet-neurological-disorders\/","url":"https:\/\/mabdesign.fr\/en\/marjet-neurological-disorders\/","name":"Market Neurological disorders - MabDesign","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/marjet-neurological-disorders\/#primaryimage"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/marjet-neurological-disorders\/#primaryimage"},"thumbnailUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/03\/Neurology-Market-flyer.png","datePublished":"2024-02-15T08:15:51+00:00","dateModified":"2025-03-27T10:10:18+00:00","description":"MabDesign's market analysis gives you an overview of market dynamics and projects in development targeting neurological disorders.","breadcrumb":{"@id":"https:\/\/mabdesign.fr\/en\/marjet-neurological-disorders\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mabdesign.fr\/en\/marjet-neurological-disorders\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/marjet-neurological-disorders\/#primaryimage","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/03\/Neurology-Market-flyer.png","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/03\/Neurology-Market-flyer.png","width":1500,"height":2000,"caption":"troubles neurologiques, pipeline, march\u00e9, neurological disorders"},{"@type":"BreadcrumbList","@id":"https:\/\/mabdesign.fr\/en\/marjet-neurological-disorders\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/mabdesign.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Neurological disorders"}]},{"@type":"WebSite","@id":"https:\/\/mabdesign.fr\/en\/#website","url":"https:\/\/mabdesign.fr\/en\/","name":"Mabdesign","description":"The Biotherapy Expert","publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mabdesign.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/mabdesign.fr\/en\/#organization","name":"Mabdesign","url":"https:\/\/mabdesign.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","width":786,"height":233,"caption":"Mabdesign"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/MabDesign_fr","https:\/\/www.linkedin.com\/company\/mabdesign\/"]},{"@type":"Person","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/4643f9d895805d8377e2471c8e4d6918","name":"Anabelle Perrier","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f3a0b000cbed04b58d93c3453cafdf5ef34c998ff91ba6a81b173a075a0bfae2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f3a0b000cbed04b58d93c3453cafdf5ef34c998ff91ba6a81b173a075a0bfae2?s=96&d=mm&r=g","caption":"Anabelle Perrier"},"url":"https:\/\/mabdesign.fr\/en\/author\/anabelle-perriermabdesign-fr\/"}]}},"_links":{"self":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/22890","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/comments?post=22890"}],"version-history":[{"count":10,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/22890\/revisions"}],"predecessor-version":[{"id":24423,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/22890\/revisions\/24423"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media\/22778"}],"wp:attachment":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media?parent=22890"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/categories?post=22890"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/tags?post=22890"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}